EVRY, France, June 27, 2016 -- Global Bioenergies (Alternext Paris: ALGBE) announces having delivered isobutene produced at its industrial pilot to Clariant, a leading specialty chemical company.
Clariant is a Swiss stock-market listed company with revenues exceeding 5 billion euros in 2015, active in a variety of chemical markets such as specialty polymers.
Global Bioenergies' most advanced program consists in the production of high-purity isobutene from renewable resources. A sample of such renewable isobutene, produced at the company's industrial pilot plant, has been shipped to Clariant, where tests regarding Clariant's application of interest have been carried out successfully.
Thomas Buhl, Head of Business Development at Global Bioenergies comments: "After Cristal Union, Audi, Arkema, CFBP, Arlanxeo and L'Oréal, we are pleased to add a seventh company to our list of major industrialists interested in our technology. Clariant is known for developing innovative solutions towards a more environment-friendly chemistry, a mission shared by Global Bioenergies."
About GLOBAL BIOENERGIES
Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the performances of its process, operates its industrial pilot, builds its demo plant in Germany, and prepares the first full-scale plant through a Joint-Venture with Cristal Union, named
IBN-One. The company also replicated its achievement to propylene and butadiene, two members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE).
Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com
Follow us on Twitter: @GlobalBioenergi
Contact
GLOBAL BIOENERGIES
Thomas BUHL
Head of Business Development
Phone: +33 (0)1 64 98 20 50
Email: [email protected]
Press release http://hugin.info/166909/R/2023313/751756.pdf
HUG#2023313


NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
OpenAI Addresses Security Vulnerability in macOS App Certification Process
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 



